Prestige BioPharma Limited (KRX:950210)
South Korea flag South Korea · Delayed Price · Currency is KRW
13,270
0.00 (0.00%)
At close: Jun 5, 2025, 3:30 PM KST

Prestige BioPharma Revenue

Prestige BioPharma had revenue of 3.34B KRW in the quarter ending March 31, 2025, with 422.99% growth. This brings the company's revenue in the last twelve months to 8.66B, up 776.76% year-over-year. In the fiscal year ending June 30, 2024, Prestige BioPharma had annual revenue of 689.08M with 325.77% growth.

Revenue (ttm)
8.66B
Revenue Growth
+776.76%
P/S Ratio
18.41
Revenue / Employee
160.42M
Employees
54
Market Cap
159.50B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Jun 30, 2024689.08M527.23M325.77%
Jun 30, 2023161.84M--
Jun 30, 2022---
Jun 30, 2021---
Jun 30, 2020---
Jun 30, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Samsung Biologics 4,898.69B
Celltrion 3,662.23B
ALTEOGEN 151.65B
Yuhan 2,114.76B
SK Biopharmaceuticals 578.00B
HLB Co., Ltd. 74.64B
PharmaResearch 392.31B
LigaChem Biosciences 146.42B
Revenue Rankings